NON-FUNCTIONING PITUITARY ADENOMAS : A PLEA FOR AN EARLIER DIAGNOSIS

被引:0
|
作者
Yvan, Zunon-Kipre [1 ]
Esperance, Broalet [1 ]
Landry, Drogba [1 ]
Aderehime, Haidara [1 ]
Herman, N'Da [1 ]
Vincent, Bazeze [1 ]
机构
[1] CHU dAbidjan Yopougon, Serv Neurochirurg, Abidjan, Cote Ivoire
来源
关键词
diagnosis; gonadothropin pituitary adenoma; non secreting adenomas; pituitary tumor;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Clinically silent pituitary adenomas are not diagnosed because of hormonal hypersecretion. They are detected late when the optic pathway is compressed. The objective of this work is to define clinical and biological profile which will allow an early diagnosis. Material and methods 44 files of patients operated on between 1994 and 2005 were analyzed. They all had macroadenomas of different histochemical types. Sex, gynecological and obstetrical history, age, delay before diagnosis, circumstances of diagnosis and clinical data were obtained in each case. Basic gonadotrophins level, GnRH and TRH dynamical tests were separately performed in men, sexually active women and women in menopause. Histopathology and immunohistochemistry studies were performed. Results the series comprised 28 men(63.6%) and 16 women (36.4%) (10 of them were in menopause). Mean age was 58.5 years and diagnostic delay was 9.5 months. Tumoral syndrome was present in 86.4 % of cases, all the patients had visual impairment, mainly visual's field amputation or restriction. Hypopituitarism syndrome was present (41 %) according to the degree of compression or destruction of the normal pituitary gland by the tumor, except for gonadotrophic hypersecretion signs (9.1%). Hormonal dosage showed more than 60% of pituitary gland insufficiency in all three groups, particularly the gonadotrophic one. Moderate prolactin hypersecretion was found in 41 to 89% of cases, but the absolute value was always less than 150 ng/ml At histoimmunochemistry, gonadotroph cell adenomas predominate (81.8%), followed by the real non-secreting one(11%), then corticotroph (4.5%) and lastly the multi-secreting adenomas (2.3%) Conclusion The clinical syndrome of non secretory pituitary adenoma is not clearly defined. Practitionners need to identify early these symptoms, which were actually present from the beginning of the clinical history, by a meticulous examination. If patient presents cephalalgia and visual impairment, cerebral CT scan or MRI explorations are mandatory to explore the presence of a pituitary tumor. In case of non-functioning pituitary adenoma, basic endocrine exploration should find a hypopituitarism, mainly gonadotropic, with a moderate prolactin hypersecretion. The dosage of a and beta ubunits must be done. Dynamic tests should be performed only in case of difficulty. Analysis is difficult in menopausal women
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [21] Optimal management of non-functioning pituitary adenomas
    Greenman, Yona
    Stern, Naftali
    ENDOCRINE, 2015, 50 (01) : 51 - 55
  • [22] Management of patients with non-functioning pituitary adenomas
    Köbberling, J
    MEDIZINISCHE KLINIK, 2003, 98 (11) : 616 - 616
  • [23] Molecular alterations in non-functioning pituitary adenomas
    Taniguchi-Ponciano, Keiko
    Gomez-Apo, Erick
    Chavez-Macias, Laura
    Vargas, Guadalupe
    Espinosa-Cardenas, Etual
    Ramirez-Renteria, Claudia
    Ferreira-Hermosillo, Aldo
    Sosa, Ernesto
    Silva-Roman, Gloria
    Pena-Martinez, Eduardo
    Andonegui-Elguera, Sergio
    Vargas-Chavez, Sonia
    Santiago-Andres, Yorgui
    Peralta, Raul
    Marrero-Rodriguez, Daniel
    Mercado, Moises
    CANCER BIOMARKERS, 2020, 28 (02) : 193 - 199
  • [24] Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
    Lenders, Nele
    McCormack, Ann
    PITUITARY, 2018, 21 (02) : 217 - 229
  • [25] Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
    Nèle Lenders
    Ann McCormack
    Pituitary, 2018, 21 : 217 - 229
  • [26] Non-Functioning Pituitary Adenomas: A Single Center Experience
    Anagnostis, P.
    Adamidou, F.
    Polyzos, S. A.
    Efstathiadou, Z.
    Panagiotou, A.
    Kita, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (05) : 314 - 319
  • [27] Telomerase expression in clinically non-functioning pituitary adenomas
    Ogino, Liana Lumi
    Lamback, Elisa Baranski
    Guterres, Alexandro
    de Azeredo Lima, Carlos Henrique
    Henriques, Daniel Gomes
    Barbosa, Monique Alvares
    Silva, Debora Aparecida
    da Silva Camacho, Aline Helen
    Chimelli, Leila
    Kasuki, Leandro
    Gadelha, Monica R.
    ENDOCRINE, 2021, 72 (01) : 208 - 215
  • [28] A Review of Treatment with Cabergoline for Non-Functioning Pituitary Adenomas
    Papneja, Netee
    Caspar-Bell, Gudrun Martina
    Imran, Syed Ali
    Cooper, Paul Edward
    Van Uum, Stan
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [29] Giant Non-Functioning Pituitary Adenomas: Treatment Considerations
    Solari, Domenico
    Cavallo, Luigi Maria
    Graziadio, Chiara
    Corvino, Sergio
    Bove, Ilaria
    Esposito, Felice
    Cappabianca, Paolo
    BRAIN SCIENCES, 2022, 12 (09)
  • [30] Are volume measurements of non-functioning pituitary adenomas reliable?
    Oystese, Kristin Astrid Berland
    Hisanawi, Sheren
    Zucknick, Manuela
    Bollerslev, Jens
    Ringstad, Geir
    ENDOCRINE, 2019, 63 (01) : 171 - 176